Evidence map›Paper›PMID 38099100›Full record

ArticleIndian journal of dermatology

Development of Consensus Recommendations on the Management of Vitiligo and the Role of Decapeptide in Vitiligo by the Delphi Method.

Davinder Parsad, Sanjeev Kandhari, Rachita Dhurat, Bela Shah, Imran Majid, Harikishan Kumar Yadalla, Jagdish Sakhiya, Shital Poojary, P Jagadish, Pravin D Banotkar and 11 more

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Indian journal of dermatology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Observational
  2. Recent Advances in Management of Vitiligo.Indian journal of dermatology
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 7 institutions in 1 country.

Davinder ParsadFrom the Department of Dermatology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Sanjeev KandhariKandhari's Skin and Dental Clinic, Srinagar, Jammu and Kashmir, India.
Rachita DhuratDepartment of Dermatology, LTMMC, Sion Hospital, Srinagar, Jammu and Kashmir, India.
Bela ShahDepartment of Dermatology, B. J Medical College and Civil Hospital, Srinagar, Jammu and Kashmir, India.
Imran MajidCutis Clinic, Srinagar, Jammu and Kashmir, India.
Harikishan Kumar YadallaDepartment of Dermatology, Venereology and Leprosy, Rajarajeshwari Medical College, Surat, Gujarat, India.
Jagdish SakhiyaSakhiya Skin Clinic, Surat, Gujarat, India.
Shital PoojaryDepartment of Dermatology, KJ Somaiya Medical College, Bengaluru, Karnataka, India.
P JagadishCuticare Centre, Bengaluru, Karnataka, India.
Pravin D BanotkarSaifee Hospital, Bengaluru, Karnataka, India.
Ravindra BabuRaga Clinic, Bengaluru, Karnataka, India.
Y M ShivakumarInchara Skin Clinic, Mysore, Karnataka, India.
S K BoseIndraprastha Apollo, Gadag, Karnataka, India.
Saleem JamadarShifa Clinic, Gadag, Karnataka, India.
Monal ShahHaribhakti Skin Clinic, Ahmedabad, Gujarat, India.
Bharat TankAmrut Skin Clinic, Rajkot, Gujarat, India.
Ravindra DhabhaiSikar Hospital and Research Centre, Sikar, Rajasthan, India.
Sanjay Kumar MittalMittal Skin Clinic, Jaipur, Rajasthan, India.
Premanshu BhushanDr. P N Behl Skin Institute, New Delhi, Delhi, India.
Akshi PanditaDr. P N Behl Skin Institute, New Delhi, Delhi, India.
Vaibhav BarveKJ Somaiya Medical College, Mumbai, Maharashtra, India.
Shri Maharaja Hari Singh Hospital · INBangalore Diabetes Centre · INCluster University Srinagar · INK J Somaiya Medical College · INPost Graduate Institute of Medical Education and Research · INRajarajeswari Medical College and Hospital · INSher-i-Kashmir Institute of Medical Sciences · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Treatment of vitiligo is still a challenge in dermatology. Literature is sparse on the definitive clinical role of basic fibroblast growth factor (bFGF) in vitiligo patients. Aims: We decided to generate a consensus in an attempt to answer some critical questions related to the management of vitiligo and the role of bFGF. Materials and Methods: A Delphi method among 21 experts across India was conducted. A consensus (agreement was 75% or greater) was taken on 27 statements on the prevalence, epidemiology, and treatment of vitiligo and the role of bFGF in the management of vitiligo. The consensus process was completed after two rounds. Results: Topical corticosteroid therapy is the first-line therapy for vitiligo; however, its adverse effects are widely known, especially in sensitive areas. Topical calcineurin inhibitors are preferred in stable vitiligo of the face, neck, genitals, or intertriginous regions as an alternative to topical corticosteroids. Topical bFGF is a relatively newer therapy with a promising role in stable vitiligo. bFGF is safe and effective in inducing repigmentation of vitiligo lesions. Combination therapy of bFGF with other topical therapies, phototherapy, and surgical procedures can be beneficial in patients of vitiligo. Conclusion: This consensus would complement the currently available literature on bFGF and help the practitioner to recognize the unmet need in the treatment of vitiligo.

Indexed as

bFGFconsensusDelphi methodrecommendationsvitiligo

Identifiers

PMID38099100
PMCPMC10718246
OpenAlexW4389799961

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.